Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals    VRTX

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Vertex Pharmaceuticals
Discovers and develops novel, small molecule pharmaceuticals

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases.

It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis.

The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Number of employees : 2 150 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals1,032100%1,702100% +64.89%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States763.3273.9%1,32277.7% +73.17%
Europe219.6021.3%320.4618.8% +45.93%
Other49.424.8%59.913.5% +21.22%
Managers
NameAgeSinceTitle
Jeff Leiden612009Chairman, President & Chief Executive Officer
Ian F. Smith512001EVP, Chief Operating & Financial Officer
Jeffrey A. Chodakewitz, MD612014Chief Medical Officer & Executive Vice President
David Matthew Altshuler MD, PhD522012Chief Scientific Officer & EVP-Global Research
Reshma Kewalramani-2017Senior VP-Clinical Development & Medical Affairs
Bruce I. Sachs, MBA571998Lead Independent Director
Elaine S. Ullian691997Lead Independent Director
Margaret G. McGlynn, MBA572011Independent Director
Terrence C. Kearney, MBA622011Independent Director
Yuchun Lee, MBA512012Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 250,770,000 247,941,318 98.9% 0 0.0% 98.9%
Shareholders
NameEquities%
T. Rowe Price Associates, Inc. 22,978,643 9.23%
Capital Research & Management Co. (World Investors) 17,900,933 7.19%
Wellington Management Co. LLP 17,765,933 7.13%
Fidelity Management & Research Co. 17,498,169 7.03%
The Vanguard Group, Inc. 16,474,890 6.61%
BlackRock Fund Advisors 13,475,197 5.41%
SSgA Funds Management, Inc. 12,013,178 4.82%
ClearBridge Investments LLC 8,754,618 3.51%
Columbia Management Investment Advisers LLC 7,307,360 2.93%
JPMorgan Investment Management, Inc. 6,721,989 2.70%
Holdings
NameEquities%Valuation
Crispr Therapeutics AG (CRSP) 3,186,5867.92%51,049,108 USD
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
VERTEX PHARMACEUTICALS112.01%40 703
AMGEN17.74%129 349
CELGENE CORPORATION15.90%107 559
GILEAD SCIENCES4.68%96 946
REGENERON PHARMACEUTICALS40.46%54 807
ACTELION21.32%30 573
GENMAB21.74%13 782
EXELIXIS, INC.81.82%8 196
TESARO INC-5.79%7 006
BIOVERATIV INC0.00%6 863
KITE PHARMA INC142.82%6 290
BLUEBIRD BIO INC55.35%4 451
NEUROCRINE BIOSCIENCES, INC.26.18%4 316
TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.-23.16%4 274
CLOVIS ONCOLOGY INC107.68%4 212
HUALAN BIOLOGICAL ENGINEERING INC--.--%3 885
BIOCON LTD28.24%3 775
PEPTIDREAM INC-41.45%3 593
INTERCEPT PHARMACEUTICALS INC19.25%3 222
JUNO THERAPEUTICS INC52.04%3 210
ULTRAGENYX PHARMACEUTICAL INC0.74%2 997
Connections : Vertex Pharmaceuticals
Nantero, Inc.
National Academy of Sciences
iControl Networks, Inc.
The American Institute of Certified Public Accountants
DataGravity, Inc.
Institute of Chartered Accountants in England & Wales
The Brigham & Women's Hospital, Inc.
The Financial Executives Institute
SpiderCloud Wireless, Inc.
Macp Organization
Jibo, Inc.
Infectious Diseases Society of America
The Boston Private Industry Council, Inc.
Biotechnology Innovation Organization
Association of American Physicians
American Academy of Arts & Sciences
Accelerated Cure Project for Multiple Sclerosis
Massachusetts Mutual Life Insurance Co.
SimpliVity Corp.
The Museum of Fine Arts
GreatCall, Inc.
Institute of Medicine
OneCloud Software, Inc.
Clarabridge, Inc.
Charles River Ventures, Inc.
The American Society for Clinical Pharmacology & Therapeutics
Vertex Pharmaceuticals
HCU Network America
Abington Friends School
New England Aquarium Corp.
Massachusetts Institute of Technology
Orphan Technologies Ltd.
The Broad Institute, Inc.
Whitehead Institute for Biomedical Research
Allego, Inc.
American Society for Clinical Investigation
General Catalyst Partners LLC
Company contact information
50 avenue Northern
US-MA 02110 Boston, Massachusetts
États-Unis (les)

Phone : +1 617 444 6100
Fax : +1 617 444 6680
Internet : http://www.vpharm.com
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 / SP500
Stock Exchange Codes
- ISIN Code :  US92532F1003
- Bloomberg Code :  VRTX:US
- Reuters Code :  VRTX.O
- Datastream Code :  
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem